aciclovir agepha silmasalv
agepha pharma s.r.o. - atsikloviir - silmasalv - 30mg 1g 4.5g 1tk
ultracortenol silmasalv
agepha pharma s.r.o. - prednisoloon - silmasalv - 5mg 1g 5g 1tk
novain silmatilgad, lahus
agepha pharma s.r.o. - oksübuprokaiin - silmatilgad, lahus - 4mg 1ml 10ml 1tk
mydriaticum agepha silmatilgad, lahus
agepha pharma s.r.o. - tropikamiid - silmatilgad, lahus - 5mg 1ml 10ml 1tk
nitrofurantoin agepha tablett
agepha pharma s.r.o. - nitrofurantoiin - tablett - 50mg 20tk
xylo-mepha ninasprei, lahus
mepha-investigacao, desenvolvimento e fabricacao farmaceutica, lda - ksülometasoliin - ninasprei, lahus - 0,5mg 1ml 10ml 1tk
xylo-mepha ninasprei, lahus
mepha-investigacao, desenvolvimento e fabricacao farmaceutica, lda - ksülometasoliin - ninasprei, lahus - 1mg 1ml 10ml 1tk
azimepha 500 mg õhukese polümeerikattega tablett
mepha-investigacao, desenvolvimento e fabricacao farmaceutica, lda - asitromütsiin - õhukese polümeerikattega tablett - 500mg 2tk; 500mg 30tk; 500mg 6tk; 500mg 150tk
azimepha 250 mg õhukese polümeerikattega tablett
mepha-investigacao, desenvolvimento e fabricacao farmaceutica, lda - asitromütsiin - õhukese polümeerikattega tablett - 250mg 4tk; 250mg 6tk; 250mg 3tk; 250mg 100tk
budesonide/formoterol teva pharma b.v.
teva pharma b.v. - budesonide, formoterol - astma - ravimid hingamisteede obstruktiivsete haiguste, - budesonide / formoterol teva pharma b. on näidustatud ainult 18-aastastel ja vanematel täiskasvanutel. asthmabudesonide/formoterol teva pharma b. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists. in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.